XML 107 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense and related tax benefits for the years ended December 31, 2019, 2018 and 2017 was as follows:
Year Ended December 31,
201920182017
(in thousands) 
Stock options$2,623  $2,989  $3,740  
Restricted stock units and restricted stock3,967  2,591  1,205  
Employee Stock Purchase Plan 275  320  1,040  
Total pre-tax stock-based compensation expense charged against income 1
$6,865  $5,900  $5,985  
Total recognized tax benefit related to stock-based compensation$196  $1,480  $5,709  

1.Stock-based compensation expense is recorded in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.
Summary of Stock Options Activity
A summary of stock options outstanding under the Plan as of December 31, 2019 and changes during 2019 is as follows:
 
Number of Shares
Weighted Average Exercise Price
(in thousands) 
December 31, 20182,121  $31.53  
Granted188  $40.49  
Exercised(163) $22.32  
Forfeited(23) $36.49  
Expired(16) $31.37  
December 31, 20192,107  $32.99  
Assumption for Fair Value of Options Granted
The fair value of the stock option awards granted during 2019, 2018 and 2017 were estimated on the dates of grant using the Black-Scholes option valuation model and the following assumptions:
Year Ended December 31,
201920182017
Risk-free interest rate2.5 %2.1 %2.0 %
Weighted average expected life5.7 years5.8 years5.8 years
Expected volatility22.6 %21.5 %25.1 %
Dividend yield1.9 %1.5 %1.9 %
Summarized Information of Stock Options Outstanding
The following table summarizes other information about the stock options at December 31, 2019:
December 31, 2019
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$2,121  
Weighted average remaining contractual life5.4 years
Exercisable:
Number of options1,256  
Weighted average exercise price$28.45  
Aggregate intrinsic value$2,121  
Weighted average remaining contractual life4.3 years
Summary of Stock Options Outstanding
A summary of the outstanding restricted stock units and restricted stock as of December 31, 2019 and changes during 2019 is as follows:
Restricted Stock Units and Restricted Stock
NumberWeighted Average Grant Date Fair Value
(in thousands) 
December 31, 2018241  $45.47  
Granted194  $40.49  
Vested(61) $43.04  
Forfeited(12) $44.47  
December 31, 2019362  $43.24  
Weighted Average Grant-Date Fair Values and Intrinsic Values of Options Vested
The weighted average grant-date fair values and total fair values of restricted stock units and restricted stock vested during 2019, 2018 and 2017 were as follows:
Year Ended December 31,
201920182017
(in thousands, except per share data)
Weighted average grant-date fair value of restricted stock units and restricted stock granted$40.49  $52.06  $40.16  
Total fair value of restricted stock units and restricted stock vested$2,399  $1,822  $690  
Summary of ESPP Annual Offerings
The following table summarizes information about the Company’s ESPP annual offerings for the years ended December 31, 2019, 2018 and 2017:
Year Ended December 31,
 201920182017
(in thousands, except per share data)
Common shares purchased75  53  54  
Per common share purchase price$20.67  $34.15  $33.29  
Summary of Information Of SERP
The following table summarizes information about the SERP for the plan years ended December 31, 2019, 2018 and 2017:
Year Ended December 31,
 201920182017
(in thousands) 
SERP expense 1
$539  $547  $503  
Treasury shares issued to fund SERP expense 2
22  14   
SERP trust account balance at December 31 3
$43,952  $39,766  $42,467  
Unrealized gain (loss) recorded in SERP liability account$7,353  $(1,469) $4,534  
1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.
2.Shares related to the SERP match for each year are funded at the beginning of the subsequent year.
3.SERP trust account investments are recorded at their fair value which is based on quoted market prices. Differences between such amounts in the table above and the deferred compensation funding asset reported on the Consolidated Balance Sheets represent the value of Company Common Stock held in the Plan participants’ trust accounts and reported by the Company as treasury stock in the Consolidated Balance Sheets.